Safety of anti-CGRP monoclonal antibodies in patients with migraine during the COVID-19 pandemic: Present and future implications

Mostrar otras versiones (1)

BACKGROUND AND OBJECTIVE: CGRP, a neuropeptide involved in migraine pathophysiology, is also known to play a role in the respiratory system and in immunological conditions such as sepsis. We analyzed the impact of the use of CGRP antagonists in patients with migraine during the COVID-19 pandemic, ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Caronna, E., José Gallardo, V., Alpuente, A., Torres-Ferrus, M., Sánchez-Mateo, N.M., Viguera-Romero, J., López-Veloso, A.C., López-Bravo, A., Gago-Veiga, A.B., Irimia Sieira, P., Porta-Etessam, J., Santos-Lasaosa, S., Pozo-Rosich, P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedad Española de Neurología. Published by Elsevier España, S.L.U. 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8506139/
https://www.ncbi.nlm.nih.gov/pubmed/34654536
http://dx.doi.org/10.1016/j.nrleng.2021.03.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8506139/
https://www.ncbi.nlm.nih.gov/pubmed/34654536
http://dx.doi.org/10.1016/j.nrleng.2021.03.005

Ejemplares similares